Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Expert Opinion on Drug Discovery

• Publication date

  2021-05-07

• Fields of study

  Chemistry, Medicine, Computer Science

• Identifiers
  DOI 10.1080/17460441.2021.1918098PMID 33957833
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

  2021influential reference
• Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

  2021cited by this paper
• Holistic Drug Design for Multiparameter Optimization in Modern Small Molecule Drug Discovery.

  2021cited by this paper
• Accuracy or novelty: what can we gain from target-specific machine-learning-based scoring functions in virtual screening?

  2021cited by this paper
• A Modelling Framework for Embedding-based Predictions for Compound-Viral Protein Activity

  2021cited by this paper
• Contribution of machine learning approaches in response to SARS-CoV-2 infection

  2021cited by this paper
• Antiviral drug discovery: preparing for the next pandemic.

  2021cited by this paper
• Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates

  2021cited by this paper
• Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses.

  2021cited by this paper
• De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence

  2021cited by this paper
• Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2

  2020cited by this paper
• Evaluation of the performance of various machine learning methods on the discrimination of the active compounds

  2020cited by this paper
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

  2020cited by this paper
• Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection

  2020cited by this paper
• Advanced machine-learning techniques in drug discovery.

  2020cited by this paper
• Repurposing potential of FDA‐approved and investigational drugs for COVID‐19 targeting SARS‐CoV‐2 spike and main protease and validation by machine learning algorithm

  2020cited by this paper
• HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine

  2020cited by this paper
• The urgent need for pan-antiviral agents: from multitarget discovery to multiscale design

  2020cited by this paper
• Machine learning with physicochemical relationships: solubility prediction in organic solvents and water

  2020cited by this paper
• Better understanding and prediction of antiviral peptides through primary and secondary structure feature importance

  2020cited by this paper
• Machine learning for clinical trials in the era of COVID-19

  2020cited by this paper
• Freely Accessible Chemical Database Resources of Compounds for in Silico Drug Discovery.

  2020cited by this paper
• Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors

  2020cited by this paper
• QSAR Modeling of SARS‐CoV Mpro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2

  2020cited by this paper
• Quantitative Structure − Activity Relationship Machine Learning Models and their Applications for Identifying Viral 3CLpro-and RdRp-Targeting Compounds as Potential Therapeutics for COVID-19 and Related Viral Infections

  2020cited by this paper
• Danger in the Valley of Death: how the transition from preclinical research to clinical trials can impact valuations.

  2020cited by this paper
• Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases

  2020cited by this paper
• A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance

  2020cited by this paper
• Researchers are betting that AI and automation can cut drug discovery from five years to six months: Automating antivirals

  2020cited by this paper
• Artificial intelligence in COVID-19 drug repurposing

  2020cited by this paper
• Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds

  2020cited by this paper
• Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19

  2020cited by this paper
• Development of a Neural Network-Based Approach for Prediction of Potential HIV-1 Entry Inhibitors Using Deep Learning and Molecular Modeling Methods

  2020cited by this paper
• Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

  2020cited by this paper
• Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network.

  2020cited by this paper
• Emerging Pandemic Diseases: How We Got to COVID-19

  2020influential reference
• Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease

  2020cited by this paper
• Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?

  2020cited by this paper
• Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space

  2020cited by this paper
• Transfer Learning for Drug Discovery.

  2020cited by this paper
• iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding

  2020cited by this paper
• Bayer's in silico ADMET platform: a journey of machine learning over the past two decades.

  2020cited by this paper
• Artificial Intelligence in Drug Discovery: Into the Great Wide Open.

  2020cited by this paper
• Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation.

  2020cited by this paper
• Potential Emergence of Antiviral-Resistant Pandemic Viruses via Environmental Drug Exposure of Animal Reservoirs.

  2020cited by this paper
• Clinical targeting of HIV capsid protein with a long-acting small molecule

  2020cited by this paper
• Drug discovery with explainable artificial intelligence

  2020cited by this paper
• The application of machine learning techniques to innovative antibacterial discovery and development

  2020cited by this paper
• Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19

  2020cited by this paper
• Experimental Data Based Machine Learning Classification Models with Predictive Ability to Select in Vitro Active Antiviral and Non-Toxic Essential Oils

  2020cited by this paper
• Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2

  2020cited by this paper
• Chemists: AI is here, unite to get the benefits.

  2020cited by this paper
• kGCN: a graph-based deep learning framework for chemical structures

  2020cited by this paper
• Learning Molecular Representations for Medicinal Chemistry.

  2020cited by this paper
• A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing

  2020cited by this paper
• 'Ring Breaker': Neural Network Driven Synthesis Prediction of the Ring System Chemical Space.

  2020cited by this paper
• Enterovirus D68 antivirals: past, present and future.

  2020cited by this paper
• Drug Research Meets Network Science: Where Are We?

  2020cited by this paper
• Improvement in ADMET Prediction with Multitask Deep Featurization.

  2020cited by this paper
• Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

  2020cited by this paper
• Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis

  2020cited by this paper
• SARS-CoV-2 Vaccines: Status Report

  2020cited by this paper
• Principles of QSAR Modeling: Comments and Suggestions From Personal Experience

  2020cited by this paper
• Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

  2020cited by this paper
• Automated De-Novo Design in Medicinal Chemistry: Which Types of Chemistry Does a Generative Neural Network Learn?

  2020cited by this paper
• An artificial intelligence approach to pro-actively inspire drug discovery with recommendations.

  2020cited by this paper
• A Deep Learning Approach to Antibiotic Discovery.

  2020cited by this paper
• Machine learning on DNA-encoded libraries: A new paradigm for hit-finding

  2020cited by this paper
• Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.

  2020cited by this paper
• Pushing the boundaries of molecular representation for drug discovery with graph attention mechanism.

  2020cited by this paper
• The symbiotic relationship between drug discovery and organic chemistry.

  2020cited by this paper
• Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values.

  2020cited by this paper
• Industrial applications of green chemistry: Status, Challenges and Prospects

  2020cited by this paper
• Improved Deep Learning Based Method for Molecular Similarity Searching Using Stack of Deep Belief Networks

  2020cited by this paper
• Natural products against acute respiratory infections: Strategies and lessons learned.

  2020cited by this paper
• Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

  2020influential reference
• Eleven tips for working with large data sets

  2020cited by this paper
• Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods

  2020cited by this paper
• Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24

  2019cited by this paper
• Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads

  2019cited by this paper
• Enhanced taxonomy annotation of antiviral activity data from ChEMBL

  2019cited by this paper
• Machine learning on adverse drug reactions for pharmacovigilance.

  2019cited by this paper
• Applications of machine learning in drug discovery and development

  2019cited by this paper
• Repurposing Quinacrine against Ebola Virus Infection In Vivo

  2019cited by this paper
• Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method

  2019cited by this paper
• Two new molecular preprocessing schemes for machine learning and their evaluation using some DT algorithms

  2019influential reference
• Therapeutic strategies to target the Ebola virus life cycle

  2019cited by this paper
• Deep Learning Enhancing Kinome-Wide Polypharmacology Profiling: Model Construction and Experiment Validation.

  2019cited by this paper
• A comparison of machine learning algorithms for the prediction of Hepatitis C NS3 protease cleavage sites

  2019cited by this paper
• Machine Learning Models for Accurate Prediction of Kinase Inhibitors with Different Binding Modes.

  2019cited by this paper
• Practical High-Quality Electrostatic Potential Surfaces for Drug Discovery Using a Graph-Convolutional Deep Neural Network.

  2019cited by this paper
• Meta-iAVP: A Sequence-Based Meta-Predictor for Improving the Prediction of Antiviral Peptides Using Effective Feature Representation

  2019cited by this paper
• Prediction and Interpretable Visualization of Retrosynthetic Reactions Using Graph Convolutional Networks

  2019cited by this paper
• Rethinking drug design in the artificial intelligence era

  2019cited by this paper
• Practical considerations for active machine learning in drug discovery.

  2019cited by this paper
• Generative topographic mapping in drug design.

  2019cited by this paper
• Rewiring cellular networks by members of the Flaviviridae family

  2018cited by this paper
• Machine Learning in Computer-Aided Synthesis Planning.

  2018cited by this paper
• Antibiotic Discovery

  2018cited by this paper
• Drug Analogs from Fragment-Based Long Short-Term Memory Generative Neural Networks

  2018cited by this paper

• Generative Artificial Intelligence for Virology.

  2025cites this paper
• Fast and flu-rious: How to prevent and treat emerging influenza A viruses

  2025cites this paper
• Challenges and limitations of computer-aided drug design.

  2025cites this paper
• AΙ-Driven Drug Repurposing: Applications and Challenges

  2025cites this paper
• Deep learning architectures for influenza dynamics and treatment optimization: a comprehensive review

  2025cites this paper
• Discovery of Arylfuran and Carbohydrate Derivatives from the BraCoLi Library as Potential Zika Virus NS3pro Inhibitors

  2025cites this paper
• Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article

  2025cites this paper
• Integrative computational approaches in the quest for novel Ebolavirus therapeutics

  2025cites this paper
• Aminopyrimidine Derivatives as Multiflavivirus Antiviral Compounds Identified from a Consensus Virtual Screening Approach

  2024cites this paper
• Artificial intelligence for drug repurposing against infectious diseases

  2024cites this paper
• Overcoming class imbalance in drug discovery problems: Graph neural networks and balancing approaches.

  2023cites this paper
• Antiviral Approaches against Influenza Virus

  2023cites this paper
• Synthetic Curcumin Analogues Present Antiflavivirus Activity In Vitro with Potential Multiflavivirus Activity from a Thiazolylhydrazone Moiety

  2023cites this paper
• Can Artificial Intelligence Accelerate Fluid Mechanics Research?

  2023cites this paper
• The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study

  2023cites this paper
• Advancement of Computational Design Drug Delivery System in COVID-19: Current Updates and Future Crosstalk- A Critical Update

  2023cites this paper
• Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance

  2022cites this paper
• GCN-Based Structure-Activity Relationship and DFT Studies of Staphylococcus aureus FabI Inhibitors

  2022cites this paper
• Designing drugs when there is low data availability: one-shot learning and other approaches to face the issues of a long-term concern

  2022cites this paper
• A survey on computational methods in discovering protein inhibitors of SARS-CoV-2

  2021cites this paper
• Computational anti-COVID-19 drug design: progress and challenges

  2021cites this paper
• Machine learning & deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.

  2021cites this paper
• Molecular insights on ABL kinase activation using tree-based machine learning models and molecular docking

  2021cites this paper
• Can Artificial Intelligence Accelerate Fluid Mechanics Research?

  year unknowncites this paper